SME Spotlight – Stratophase
September 1, 2017
Stratophase is an SME integrated biotech tools company that is developing services and technologies to accelerate and optimize the commercialization of biologics. This is achieved by the adaptive control and optimization of upstream bioreactor environments using its patented Ranger® optical sensing technology. Stratophase’s focus is upstream process development through pilot plant activities into clinical and cGMP manufacturing. Ranger is scale and modality independent and enables cell culture optimization to be achieved in real-time through the in-situ, real time monitoring of metabolic activity as reported in the composition of the culture media.
Stratophase has a wealth of application data and expertise gained through its on-going collaborations with industry-leading biopharma innovators which will be employed in the company’s collaborations with NIIMBL partners.
To date, Stratophase has worked with a number of leading US biopharmaceutical companies to develop and refine its technology. NIIMBL’s mission and structure is the perfect forum for Stratophase to expand and continue its efforts to advance the technology and to introduce, demonstrate, and deploy its services to the US biopharmaceutical manufacturing sector.
Stratophase was established in 1999 and is based in Southampton, UK with U.S. operations in Massachusetts.